civil-litigation federal-courts court-watch

ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED et al: Order Reassigning Case

24-cv-05887 D.N.J.
Active Court order issued Sign in to follow this case
Share mail
Advertisement
description

Case Summary

An order reassigning the case of ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED et al has been issued. The District of New Jersey is handling this matter under docket number 24-cv-05887. Case reassignment is an administrative action by the court. It typically involves moving the case to a different judge or division for case management purposes.

Stage

Court order issued

Timeline

4 events

Coverage

4 articles

Sources

1

Key Issues

  • Case reassignment
  • Patent litigation
  • Pharmaceuticals
smart_toy Juryvine case summary generated from primary court records. How we verify our work.
fact_check

Docket Snapshot

account_balance

Court

D.N.J.

District of New Jersey · 3rd Circuit · NJ

tag

Docket

Not captured

Civil

timeline

Stage

Court order issued

Active

event

Filed

Date unavailable

Not in the available feed

new_releases

Latest Filing

3:24-cv-10628 ASTRAZENECA PHARMACEUTICALS LP et al v. CIPLA LIMITED et al

Order · Apr 29, 2026

newspaper

Coverage

4 articles

1 source tracked

groups

Participants

2 Defendants, 1 Plaintiff

3 linked entities

gavel

Judge

Not assigned in feed

What the record shows

This case is tied to District of New Jersey, a federal district court in NJ.

The newest docket activity we have is a order dated April 29, 2026.

The visible party/entity graph currently includes NATCO PHARMA LIMITED, Cipla Limited, Astrazeneca Pharmaceuticals LP.

Press monitoring has found 4 related articles from 1 distinct source.

chronic

The Story So Far

Updated 4 days, 18 hours ago

ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED et al: Order Reassigning Case is an active civil matter in District of New Jersey under docket 24-cv-05887.

The dispute currently identifies 3:24-cv-05887 ASTRAZENECA PHARMACEUTICALS LP, 3:24-cv-07346 ASTRAZENECA PHARMACEUTICALS LP, and 3:24-cv-10624 ASTRAZENECA PHARMACEUTICALS LP on one side and CIPLA LIMITED and NATCO PHARMA LIMITED on the other. The case is currently organized around Order Reassigning Case.

The available docket gives enough signal to track the case, but not enough to overstate the merits. This page will become more useful as filings, orders, hearings, and party appearances add detail.

On April 29, 2026, the docket recorded a order: The court issued an order.

The next thing to watch is whether the latest order produces a substantive order, a scheduling change, a settlement signal, or a filing that clarifies the parties' positions.

smart_toy Juryvine case narrative generated from the full docket timeline. How we verify our work.

About This Court

District of New Jersey (D.N.J.) is a federal district court in the 3rd Circuit, NJ.

Advertisement

Case Timeline

4 events
gavel
Order April 29, 2026

3:24-cv-10628 ASTRAZENECA PHARMACEUTICALS LP et al v. CIPLA LIMITED et al

The court issued an order.

gavel
Order April 29, 2026

3:24-cv-10624 ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED et al

The court issued an order.

gavel
Order April 29, 2026

3:24-cv-07346 ASTRAZENECA PHARMACEUTICALS LP et al v. CIPLA LIMITED et al

The court issued an order.

gavel
Order April 29, 2026

3:24-cv-05887 ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED et al

The court issued an order.

Advertisement
newspaper

Press Coverage

4 articles
settings_backup_restore Data provenance expand_more

Sources tracked

1 outlet · 4 articles

Timeline events

4 records on file

Last updated

4 days, 4 hours ago

Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.